Lyons Corporate Market Limited announced its unaudited financial results for the quarter and nine months ended December 31, 2025, following approval by the Board of Directors at their meeting held on February 12, 2026. The company submitted these results pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Quarterly Financial Performance

The company's financial performance for Q3 FY26 showed mixed results compared to previous periods. Interest income, which forms the primary revenue source, declined sequentially but showed year-over-year growth.

Expense Analysis

Total expenses for the quarter amounted to ₹31.03 lakhs, slightly lower than the previous quarter's ₹31.85 lakhs but marginally below the ₹31.60 lakhs recorded in Q3 FY25. Finance costs remained the largest expense component at ₹20.60 lakhs, followed by employee benefits expenses of ₹7.68 lakhs.

Nine-Month Performance Overview

For the nine months ended December 31, 2025, Lyons Corporate Market Limited reported total income of ₹90.14 lakhs compared to ₹72.90 lakhs in the corresponding period of the previous year, representing a growth of 23.6%. Interest income for the nine-month period stood at ₹82.94 lakhs, significantly higher than ₹63.10 lakhs in the previous year.

Despite higher revenues, the company recorded a net loss of ₹5.27 lakhs for the nine-month period, which was substantially better than the ₹52.74 lakhs loss reported in the corresponding period of FY25.

Key Financial Metrics

The company maintained its paid-up equity share capital at ₹467.80 lakhs with a face value of ₹10 per share. Earnings per share for the quarter stood at negative ₹0.05, an improvement from negative ₹0.17 in Q3 FY25. For the nine-month period, EPS was negative ₹0.11 compared to negative ₹1.13 in the previous year.

Regulatory Compliance and Audit

The unaudited financial results were reviewed by SRB & Associates, Chartered Accountants, who issued a limited review report. The auditors confirmed that the financial statements were prepared in accordance with Indian Accounting Standard 34 "Interim Financial Reporting" and other applicable accounting principles. The Board meeting commenced at 3:00 PM and concluded at 3:30 PM on February 12, 2026, with Managing Director Suvabrata De signing off on the results.

Lyons Corporate Market Limited has announced a key board appointment, strengthening its corporate governance structure with the addition of an experienced independent director to oversee company operations and strategic decisions.

Board Appointment Details

The company's Board of Directors, during their meeting held on December 30, 2025, appointed Mrs. Madhu Jain as Additional Director in the category of Non-Executive Independent Director. The appointment became effective from December 30, 2025, for a period of 5 years.

Director Profile and Qualifications

Mrs. Madhu Jain, aged 66 years, holds a Bachelor's degree in Arts from Ravi Shankar University, Raipur. She brings significant experience to the board, having served as an Independent Director in listed companies for the past 8 years. She has also served as a member of Audit Committee and Nomination and Remuneration Committee.

Regulatory Compliance

The appointment has been announced under Regulation 30 of SEBI (LODR) Regulations, 2015, ensuring compliance with stock exchange disclosure requirements. The company has confirmed that Mrs. Jain is not debarred from holding the office of Director by virtue of any SEBI order or any other authority. She has provided declarations confirming her independence as prescribed under the Companies Act and Listing Agreement.

Shareholder Approval Required

The appointment is subject to approval from the company's members, following standard corporate governance procedures for director appointments. This requirement ensures that shareholders have a voice in key board composition decisions.

Company Information

Lyons Corporate Market Limited operates from its registered office at 33A, Jawaharlal Nehru Road, Kolkata, and is listed on stock exchanges with BSE Scrip Code 531441 and CSE Scrip Code 022036. The company's CIN is L74140WB1994PLC061497.